Reversible cardiogenic shock after low dose oral propranolol
Swanson, H.; Beauchamp, G.D.; Bell, H.; Kindred, L.
Journal of the Kansas Medical Society 76(11): 260-262
1975
ISSN/ISBN: 0022-8699 PMID: 1185021 Document Number: 86212
Document emailed within 1 workday
Related Documents
Smulski, H.; Sawiński, J.; Fiedorowicz-Fabrycy, I. 1975: Irreversible cardiogenic shock in a patient with implanted pacemaker following on oral dose of oxprenolol (Coretal-Polfa) Kardiologia Polska 18(2): 187-189Mattace, R.; Zacà, F.; Bugiardini, R.; Puddu, P.; Lenzi, S. 1981: Lack of incretion of insulin in the blood in reversible cardiogenic shock Bollettino Della Societa Italiana di Cardiologia 26(10): 1391-1394
Akhtar, S.S.; Wani, B.A.; Bano, Z.A.; Salim, K.P.; Handoo, F.A. 1996: 5-Fluorouracil-induced severe but reversible cardiogenic shock: a case report Tumori 82(5): 505-507
Lillehei, R.C.; Dietzman, R.H.; Motsay, G.J.; Schultz, L.S.; Romero, L.H.; Beckman, C.B. 1972: The pharmacologic approach to the treatment of shock. I. Defining traumatic, septic, and cardiogenic shock Geriatrics 27(7): 73-83
Ijima, H.; Sato, I.; Hori, M. 1974: Difference in the effects of hemorrhagic shock and cardiogenic shock on the superior and inferior venae cavae , circulation Kyobu Geka. Japanese Journal of Thoracic Surgery 27(8): 566-572
Albani, F.; Riva, R.; Baldrati, A.; Cortelli, P.; Perucca, E.; Procaccianti, G.; Baruzzi, A. 1984: Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose International Journal of Clinical Pharmacology Research 4(1): 19-23
Zeymer, U.; Tebbe, U.; Weber, M.; Vohringer, H.F.; Jaksch, R.; Bischoff, K.-O.; Toepel, W.; Marsalek, P.; Horn, S.; Neuhaus, K.-L. 2003: Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial Journal of Invasive Cardiology 15(7): 385-389
Bertel, O.; Straumann, E.; Balmelli, N.; Nägeli, B. 1998: Cardiogenic shock Schweizerische Medizinische Wochenschrift 128(39): 1428-1435
Sandoe, E. 1970: Cardiogenic shock Nordisk Medicin 83(22): 681-689
Cohen, L.S. 1972: Treatment of cardiogenic shock. Ii South Dakota Journal of Medicine 25(12): 15-17
Lippestad, C.T. 1974: Treatment of cardiogenic shock Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 94(30): 2094-2095
Weisman, S.A. 1970: Digitalis in cardiogenic shock Geriatrics 25(10): 178-180
Chebyshev, N.S. 1977: Cardiogenic (coronary) shock Meditsinskaia Sestra 36(4): 11-15
Gupta, A.K.; Oberoi, D.K. 2006: Cardiogenic shock and hypothyroidism Journal of the Association of Physicians of India 54: 793
Sherman, D.M.; Shved, N.I. 1986: Pathogenesis of cardiogenic shock Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1986(4): 26-30
Haan, D.; Dörner, V. 1971: Diagnosis of cardiogenic shock Die Medizinische Welt 22(29): 1192-1194
Ritz, R. 1988: Pharmacotherapy of cardiogenic shock Schweizerische Medizinische Wochenschrift 118(17): 626-629
Cohen, L.S. 1973: Treatment of cardiogenic shock. Ii Connecticut Medicine 37(8): 399-400
O'Rourke, M.F. 1974: Cardiogenic shock following myocardial infarction Heart and Lung: the Journal of Critical Care 3(2): 252-257
Todd, E.P. 1979: Surgical management of cardiogenic shock Journal of the Kentucky Medical Association 77(4): 194-195